颖泰生物
(920819)
| 流通市值：41.56亿 | | | 总市值：42.04亿 |
| 流通股本：12.12亿 | | | 总股本：12.26亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,020,979,931.88 | 1,144,662,654.68 | 1,018,052,897.72 | 960,486,549.6 |
| 交易性金融资产 | - | - | 725,584.92 | 1,178,100.54 |
| 应收票据及应收账款 | 1,292,880,129.36 | 1,289,216,835.31 | 1,494,237,803.81 | 1,353,018,679.05 |
| 应收账款 | 1,292,880,129.36 | 1,289,216,835.31 | 1,494,237,803.81 | 1,353,018,679.05 |
| 应收款项融资 | 160,683,740.7 | 150,957,234.88 | 118,289,036.62 | 149,003,533.91 |
| 预付款项 | 50,709,500.34 | 39,872,787 | 61,231,201.42 | 45,795,232.45 |
| 其他应收款合计 | 98,664,274.84 | 138,415,540.33 | 72,254,555.82 | 63,803,460.22 |
| 其中:应收利息 | 4,693,694.12 | 8,357,162.74 | 6,266,286.11 | 6,523,991.66 |
| 存货 | 1,214,187,045.01 | 1,334,641,060.08 | 1,335,150,954.94 | 1,463,473,388.6 |
| 合同资产 | 7,793,306.16 | 8,249,695.18 | 15,206,998.72 | 15,068,751.17 |
| 其他流动资产 | 186,871,048.41 | 226,264,042.14 | 239,007,351.22 | 240,689,004.04 |
| 流动资产合计 | 4,032,768,976.7 | 4,332,279,849.6 | 4,354,156,385.19 | 4,292,516,699.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,581,343,770.55 | 1,594,217,542.27 | 1,700,636,156.35 | 1,754,495,860.89 |
| 投资性房地产 | 109,178,369.79 | 110,343,467.43 | 108,588,898.92 | 109,536,670.64 |
| 固定资产 | 3,387,355,531.67 | 3,475,688,820.59 | 3,042,171,583.71 | 3,144,212,629.64 |
| 在建工程 | 582,049,236.89 | 540,761,947.21 | 905,206,815.96 | 891,456,616.88 |
| 使用权资产 | 30,725,638.09 | 31,281,967.66 | 32,765,041.02 | 33,231,890.33 |
| 无形资产 | 665,470,071.53 | 672,416,280.88 | 681,656,482.72 | 691,426,073.68 |
| 商誉 | 324,276,895.66 | 324,276,895.66 | 374,366,777.39 | 374,366,777.39 |
| 长期待摊费用 | 18,118,725.81 | 19,310,540.5 | 20,480,412.42 | 21,359,494.06 |
| 递延所得税资产 | 205,074,803.68 | 201,534,031.94 | 171,070,222.32 | 161,786,992.44 |
| 其他非流动资产 | 107,376,328.01 | 93,100,852.22 | 104,544,478.87 | 80,635,617.37 |
| 非流动资产合计 | 7,010,969,371.68 | 7,062,932,346.36 | 7,141,486,869.68 | 7,262,508,623.32 |
| 资产总计 | 11,043,738,348.38 | 11,395,212,195.96 | 11,495,643,254.87 | 11,555,025,322.9 |
| 流动负债: | | | | |
| 短期借款 | 2,322,797,384.8 | 2,391,616,247.57 | 2,566,982,443.68 | 2,427,103,258.64 |
| 交易性金融负债 | 3,127,642.63 | 1,370.4 | - | - |
| 应付票据及应付账款 | 1,437,337,451.98 | 1,558,120,610.35 | 1,306,166,670.33 | 1,525,036,684.47 |
| 其中：应付票据 | 690,393,650.05 | 837,490,931.97 | 643,307,455.34 | 583,388,059.29 |
| 应付账款 | 746,943,801.93 | 720,629,678.38 | 662,859,214.99 | 941,648,625.18 |
| 预收款项 | 4,682,006.99 | 4,716,628.67 | 974,558.81 | 358,757.04 |
| 合同负债 | 80,341,993.51 | 124,143,138.63 | 90,299,045.08 | 45,770,303.65 |
| 应付职工薪酬 | 56,152,316.87 | 112,315,290.11 | 74,572,923.24 | 78,775,538.59 |
| 应交税费 | 33,325,424.29 | 47,345,707.66 | 27,519,492.06 | 30,981,930.18 |
| 其他应付款合计 | 132,292,125.01 | 139,583,321.89 | 119,866,649.09 | 128,061,335.26 |
| 一年内到期的非流动负债 | 1,118,375,982.01 | 1,191,238,423.02 | 812,942,469.55 | 990,886,595.55 |
| 其他流动负债 | 5,642,969.54 | 7,684,389.91 | 6,828,948.48 | 2,723,078.05 |
| 流动负债合计 | 5,194,075,297.63 | 5,576,765,128.21 | 5,006,153,200.32 | 5,229,697,481.43 |
| 非流动负债: | | | | |
| 长期借款 | 907,960,731.86 | 847,487,501.39 | 1,259,520,487.09 | 1,072,636,161.41 |
| 租赁负债 | 22,965,730.76 | 18,454,634.47 | 16,958,107.1 | 17,427,142.91 |
| 长期应付款 | 4,691,611.75 | 4,668,901.75 | 4,692,391.75 | 5,384,729.75 |
| 递延收益 | 129,874,737.46 | 132,449,666.42 | 114,600,478.35 | 101,280,636.51 |
| 递延所得税负债 | 46,517,085.11 | 46,661,560.32 | 46,582,292.35 | 46,648,095.64 |
| 非流动负债合计 | 1,112,009,896.94 | 1,049,722,264.35 | 1,442,353,756.64 | 1,243,376,766.22 |
| 负债合计 | 6,306,085,194.57 | 6,626,487,392.56 | 6,448,506,956.96 | 6,473,074,247.65 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 |
| 资本公积 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 |
| 其他综合收益 | -115,575,171.95 | -101,822,722.39 | -73,696,148.34 | -63,332,881.93 |
| 专项储备 | 11,479,635.05 | 8,286,758.32 | 9,672,407.87 | 9,586,516.93 |
| 盈余公积 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 |
| 未分配利润 | 400,224,085.83 | 419,970,824.71 | 667,287,935.3 | 692,205,384.78 |
| 归属于母公司股东权益合计 | 4,754,249,351.15 | 4,784,555,662.86 | 5,061,384,997.05 | 5,096,579,822 |
| 少数股东权益 | -16,596,197.34 | -15,830,859.46 | -14,248,699.14 | -14,628,746.75 |
| 股东权益合计 | 4,737,653,153.81 | 4,768,724,803.4 | 5,047,136,297.91 | 5,081,951,075.25 |
| 负债和股东权益合计 | 11,043,738,348.38 | 11,395,212,195.96 | 11,495,643,254.87 | 11,555,025,322.9 |
| 公告日期 | 2026-04-24 | 2026-04-16 | 2025-10-24 | 2025-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |